ViaSat, Inc. v. Acacia Communications, Inc. et al

Filing 112

ORDER granting 80 Joint MOTION for Discovery Determination - Discovery Dispute No. 3. Signed by Magistrate Judge Jan M. Adler on 2/15/2018. (anh)

Download PDF
1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 VIASAT, INC., etc., Case No.: 16cv463 BEN (JMA) Plaintiff/Counter-Defendant, 12 13 14 ORDER REGARDING JOINT MOTION FOR DETERMINATION OF DISCOVERY DISPUTE NO. 3 [ECF No. 80] v. ACACIA COMMUNICATIONS, INC., Defendant/Counter-Claimant. 15 16 17 18 Presently before the Court is Joint Motion for Determination of Discovery 19 Dispute No. 3 in which Defendant/Counter-Claimant Acacia Communications, 20 Inc. (“Acacia”) moves to strike portions of the deposition errata submitted by 21 deponent Chandrasekar Raj. Plaintiff/Counter-Defendant ViaSat, Inc. (“ViaSat”) 22 opposes the motion. [ECF No. 63.] As discussed further below, Acacia’s motion 23 is GRANTED. 24 A. Background Facts 25 Chandrasekar Raj (“Raj”) is the Director of Business Development for 26 ViaSat’s Cleveland office. Mr. Raj was deposed by Acacia’s counsel on October 27 13, 2017. On December 4, 2017, Raj submitted an errata sheet, making both 28 typographic and substantive changes to the deposition transcript. On December 1 16cv463 BEN (JMA) 1 18, 2017, Raj signed a declaration providing further explanations of the changes 2 in his errata sheet. Acacia seeks the strike the following changes to Raj’s testimony1: 3 4 Q: So for this particular business, ViaSat Cleveland’s business . . . does this indicate to you that at the time you sent this data sheet to ECI Tele[com], there was no NDA [non-disclosure agreement] with ECI Tele? 5 6 7 A: . . . It looks like we shared the basic data sheet. We were told an NDA was being signed, and it was signed with an effective date of March 14, 2011. 8 9 10 (Joint Mot., Exs. 3 & 4, Raj Dep., 70:2-13 & Raj. Dep. Errata.) 11 Q: So that would mean at the time that you sent this data, this product specification to them -- there was no confidentiality obligation in place between ECI Tele and ViaSat Cleveland? 12 13 14 15 MR. COCHRAN: Objection. Misstates prior testimony. 16 A: We were told an NDA was being signed, and it was in place effective March 14, 2011. So this is a product brief, a product spec that we can share. So that’s what we shared. 17 18 19 20 (Id., 70:19-71:5.) 21 Q: Okay. Would it be fair to say that this is a product specification ViaSat Cleveland was willing to share with customers without a confidentiality obligation in place with that customer? 22 23 24 A: Would Via Sat -- I don’t know, but at least for this program, it looks like it’s okay to share, you know, the basic information that I have. No. This product information was shared with an NDA in effect. 25 26 27 28                                                                   1 Raj’s additions are indicated in bold italics, and his deletions in strikethrough font. 2 16cv463 BEN (JMA) 1 Q: Okay to share this product specification -- without an NDA in place? 2 3 A: Without a full NDA in place, correct. No, this information was shared with an NDA in effect. 4 5 Q: 6 7 A: Without any NDA in place, yes. No, this information was shared with an NDA in effect. 8 9 Without any NDA in place, correct? (Id. at 71:15-72:5.) 10 Raj attests that after his deposition, he learned ViaSat “did in fact have an 11 NDA in place with ECI Telecom with an effective date of March 14, 2011.” (Raj 12 Decl., ¶ 4.) He thus made the above changes to his deposition transcript “[t]o 13 account for this fact and ensure that my deposition testimony was accurate.” 14 (Id.) 15 16 17 18 19 20 21 22 23 24 25 26 27 Acacia also seeks to strike the following changes: Q: Do you know if ViaSat would have required an NDA before sending this product specification, Exhibit 617, to a customer or potential customer? A: I cannot be sure, but, again, it depends on the customer. We may or may not have required an NDA before sending this document. We would require an NDA in order to send this document. (Joint Mot., Exs. 3 & 4, Raj Dep., 82:23-83:4 & Raj. Dep. Errata.) Q: I guess put a different way: You don’t know that ViaSat always required an NDA with a customer or potential customer before sending them Exhibit 617. Fair? A: Yes. I believe we did require an NDA before sending them this document. 28 3 16cv463 BEN (JMA) 1 2 (Id. at 83:14-18.) 4 Q: Okay, but this is not the type of product specification that ViaSat would always require an NDA before sending to a third party . . . correct? 5 .... 3 6 7 8 9 10 11 12 13 14 15 16 MR. COCHRAN: testimony. Objection. Misstates prior A: Possibly, because it’s a product spec and it looks like a high-level document to me. This form of production specification required an NDA. (Id. at 84:5-16.) Q: So it’s the kind of document that ViaSat has distributed to third parties without requiring an NDA? MR. COCHRAN: Objection. testimony. Calls for speculation. Misstates prior 17 .... 18 A: ViaSat Cleveland, you know, we may or may not have sent it without requiring NDA, and based on the document, it looks like it’s a high-level product brief. I do not believe this document was sent without knowing an NDA would be in effect. 19 20 21 22 23 24 Q: So it looks like the kind of high-level product brief that would not require an NDA before ViaSat Cleveland would send it to a third party? 25 A: Yes. No. 26 27 MR. COCHRAN: Objection. Misstates prior testimony. Calls for speculation. 28 A: Yes. No. 4 16cv463 BEN (JMA) 1 2 (Id. at 85:7-86:2.) Raj states these changes are needed because during his 3 deposition, he confused two different product specifications, each with 4 “ECC66100” in the title. (Raj Decl., ¶ 3.) He explains: 5 One product specification was two pages, and was a general, high-level product specification that was circulated without an NDA in place. The other product specification, which is the subject of my testimony on pages 83-86 of my deposition transcript, was an 8-page product specification that was not shown without an NDA in place. During my deposition, I was questioned about the 8-page product specification, but I believed that I was being asked questions about the 2-page product specification. When I reviewed my deposition transcript, I realized my mistake.” 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 (Id.) Acacia contends all of the above changes should be stricken because they are contradictory to Mr. Raj’s original testimony. ViaSat states the changes are needed to ensure “completeness” and “accuracy.” (Ex. 3.) B. Legal Standards Rule 30 of Federal Rules of Civil Procedure provides: On request by the deponent or a party before the deposition is completed, the deponent must be allowed 30 days after being notified by the officer that the transcript or recording is available in which: (A) to review the transcript or recording; and (B) if there are changes in form or substance, to sign a statement listing the changes and the reasons for making them. 23 Fed. R. Civ. P. 30(e). In 2005, the Ninth Circuit considered the scope of Rule 24 30(e) as a matter of first impression in Hambleton Bros. Lumber Co. v. Balkin 25 Enter., 397 F.3d 1217 (9th Cir. 2005). The court stated, “A statement of reasons 26 explaining corrections is an important component of errata submitted pursuant to 27 FRCP 30(e), because the statement permits an assessment concerning whether 28 the alterations have a legitimate purpose.” Hambleton, 397 F.3d at 1224-25. 5 16cv463 BEN (JMA) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 The Ninth Circuit continued: While the language of FRCP 30(e) permits corrections “in form or substance,” this permission does not properly include changes offered solely to create a material factual dispute in a tactical attempt to evade an unfavorable summary judgment. . . . . The Tenth and Seventh Circuits have interpreted FRCP 30(e) similarly. See, e.g., Burns v. Bd. of County Comm’rs, 330 F.3d 1275, 1281-82 (10th Cir. 2003) (“We see no reason to treat Rule 30(e) corrections differently than affidavits, and we hold that Burns’s attempt to amend his deposition testimony must be evaluated under [the sham affidavit doctrine].”); accord Garcia v. Pueblo Country Club, 299 F.3d 1233, 1242 n.5 (10th Cir. 2002) (“’The Rule cannot be interpreted to allow one to alter what was said under oath. If that were the case, one could merely answer the questions with no thought at all then return home and plan artful responses. Depositions differ from interrogatories in that regard. A deposition is not a take home examination.’”) (quoting Greenway v. Int’l Paper Co., 144 F.R.D. 322, 325 (W.D. La. 1992)); Thorn v. Sundstrand Aerospace Corp., 207 F.3d 383, 389 (7th Cir. 2000) (“We also believe, by analogy to the cases which hold that a subsequent affidavit may not be used to contradict the witness’s deposition, that a change of substance which actually contradicts the transcript is impermissible unless it can plausibly be represented as the correction of an error in transcription, such as dropping a ‘not.’”) (citations omitted). We agree with our sister circuits’ interpretation of FRCP 30(e) on this point, and hold that Rule 30(e) is to be used for corrective, and not contradictory, changes. 22 23 24 25 26 27 28 Hambleton, 397 F.3d at 1225-26. As recently observed by U.S. Magistrate Judge Nancy J. Koppe of the District of Nevada, district courts within the Ninth Circuit “have struggled to interpret and apply” the “corrective, and not contradictory, changes” standard in a uniform manner. Ashcraft v. Welk Resort Group Corp., 2017 WL 5180421, at *1 (D. Nev. Nov. 8, 2017). Here, as in Ashcraft, the parties ask this Court to 6 16cv463 BEN (JMA) 1 interpret this standard differently, with each side’s position supported by varying 2 district court decisions within the Ninth Circuit. The Court agrees with Judge 3 Koppe’s analysis and conclusion that “courts should limit Rule 30(e) changes to 4 those correcting stenographic mistakes and, consequently, should bar parties 5 from using Rule 30(e) to change the testimony actually given.” Id. at *4. Other 6 cases in this district have applied Rule 30(e) in a similar manner. See, e.g., 7 Tourgeman v. Collins Fin. Servs., Inc., 2010 WL 4817990 (S.D. Cal. Nov. 22, 8 2010) (Sammartino, J.); Azco Biotech Inc. v. Qiagen, N.V., 2015 WL 350567 9 (S.D. Cal. Jan. 23, 2015) (Bartick, J.); Blair v. CBE Grp. Inc.., 2015 WL 3397629 10 (S.D. Cal. May 26, 2015) (Gallo, J.). “Even though the text of Rule 30(e) allows 11 deponents to make changes ‘in form or substance,’ the rule does not allow a 12 deponent to alter what was said under oath because a deposition is not a take 13 home examination.” Ashcraft, 2017 WL 5180421 at *4 n.3; accord Blair, 2015 14 WL 3397629, at *10 (“The purpose of depositions is to determine the facts of the 15 case while the witness is under the scrutiny of examination. The purpose is 16 certainly not to find out how the witness answers questions with the ability to 17 calmly reflect on the responses for 30 days in collaboration with counsel.”).2 18 While the facts in Hambleton concerned what appeared to be “purposeful 19 rewrites” of deposition testimony “tailored to manufacture an issue of material 20 fact” for the purposes of avoiding summary judgment, found by the Ninth Circuit 21 to be akin to a “sham” affidavit, the holding of the case is not limited to those 22 facts. See, e.g., Azco Biotech, 2015 WL 350567 at *4. Furthermore, the Court 23 does not read Hambleton to apply only when a summary judgment motion is 24 pending. Tourgeman, 2010 WL 4817990 at *3. 25                                                                   26 2 27 28 “A deponent may make a formal or substantive change to correct a stenographic mistake: Should the reporter make a substantive error, i.e., he reported ‘yes’ but I said ‘no,’ or a formal error, i.e., he reported the name to be ‘Lawrence Smith’ but the proper name is ‘Laurence Smith,’ then corrections by the deponent would be in order.” Ashcraft, 2017 WL 5180421, at *4 n.3 (citations and internal quotations omitted). 7 16cv463 BEN (JMA) 1 Interpreting Rule 30(e) in a manner which prohibits a deponent from 2 changing his deposition testimony regardless of whether the deponent truly 3 believes his testimony was mistaken is consistent with important policy 4 considerations. Again, depositions are different from interrogatories as they are 5 not a “take home examination.” Garcia, 299 F.3d at 1242 n.5. Additionally, an 6 attorney is precluded from coaching a witness during his deposition. “Allowing a 7 deponent to alter testimony through after-the-fact changes (potentially in 8 consultation with [his] attorney) would undermine these well-settled deposition 9 rules, effectively permitting the substitution of interrogatory answers for 10 deposition testimony and permitting attorneys to alter the deponent’s testimony.” 11 Ashcraft, 2017 WL 5180421, at *5 (citing Greer v. Pacific Gas. & Elec. Co., 2017 12 WL 2389567, at *7 (E.D. Cal. June 1, 2017)). As such, the Court finds the 13 correct interpretation of Hambleton is that it limits the scope of Rule 30(e) 14 changes to corrections of stenographic errors, whether those corrections are of 15 form or substance, and that Rule 30(e) is not properly used to alter deposition 16 testimony provided under oath and correctly transcribed. 17 B. Discussion 18 1. 19 ViaSat contends the changes to Mr. Raj’s testimony are necessary for Raj Deposition Errata 20 “completeness” and “accuracy” reasons. (Joint Mot., Ex. 3.) Mr. Raj seeks to 21 correct his testimony in two areas of his deposition, both of which relate to 22 whether he shared ViaSat’s product specifications with or without an NDA in 23 place. In the first area of testimony (on pages 70 to 72 of his deposition 24 transcript), Raj seeks to change the transcript to reflect that he sent the product 25 specification referred to as “Exhibit 616”3 to ECI Telecom, a prospective client, 26 27 28                                                                   3 This product specification refers to a 6-page document entitled, “ECC66100 Series SD-FEC Encoder/Decoder Cores Product Specification.” See Joint Mot., Ex. 1. 8 16cv463 BEN (JMA) 1 with an NDA in effect, notwithstanding his testimony that it was “okay to share” 2 the information without an NDA in place. As set forth above, he attests he 3 learned after his deposition that ViaSat “did in fact have an NDA in place with 4 ECI Telecom with an effective date” prior to his sharing of the product 5 specification. (Raj Decl., ¶ 4.) Similarly, in the second area of testimony (on 6 pages 83 to 86 of his deposition transcript), Raj seeks to change the transcript to 7 read that ViaSat would require an NDA to be in place before sharing the product 8 specification referred to as “Exhibit 617,” despite his actual testimony that he 9 would have shared this product specification without an NDA.4 He explains that 10 he confused two different product specifications, each with “ECC66100” in the 11 title, and thought he was testifying about a 2-page product specification rather 12 than the 8-page product specification. (See Raj Decl., ¶ 3.) He makes this 13 assertion despite the fact he was shown Exhibit 617 during his deposition. (Raj. 14 Dep. at 83:3-5.) 15 The changes at issue are not permitted under Rule 30(e), as they are not 16 the result of any stenographic mistakes. Irrespective of whether the changes are 17 purposeful rewrites made to better suit the needs of ViaSat’s case or due to 18 honest mistakes by Mr. Raj at deposition, the changes are substantive and 19 directly contradict the testimony Raj provided under oath. “Changing ‘yes’ to ‘no’ 20 and ‘correct’ to ‘no not correct’ are paradigmatic examples [of] contradiction, 21 rather than correction.” Tourgeman, 2010 WL 4817990 at *2; see also Ashcraft, 22 2017 WL 5180421, at *6 (“Rule 30(e) is not the proper vehicle for trying to alter 23 unfavorable deposition testimony regardless of whether the deponent truly 24 believes upon reflection that the testimony was wrong.”) Moreover, ViaSat’s 25 counsel was present at the deposition and had an opportunity to question Raj to 26 27 28                                                                   4 Exhibit 617 consists of an 8-page document entitled, “ECC66100.SD15 Turbo Product Code Encoder/Decoder Cores Product Specification.” (Joint Mot., Ex. 2.) 9 16cv463 BEN (JMA) 1 clear up any inaccuracies. There is no indication that counsel asked any 2 clarifying questions or “attempt[ed] to rehabilitate his client regarding the 3 responses in dispute, although that is a major part of counsel’s role at the 4 depositions.” Blair, 2015 WL 3397629, at *10. Counsel may not prompt a 5 witness during a deposition, and should not be permitted to do so after the 6 deposition. Id. ViaSat’s contention that the Court should not strike the changes 7 in the errata sheet because documentary evidence corroborates the changes is 8 unavailing. “[W]hether other evidence supports the proposed changes is not the 9 standard under Rule 30(e).” Azco Biotech, 2015 WL 350567, at *4. 10 The Court notes that Mr. Raj is not precluded from later clarifying or 11 correcting any testimony he believes to be erroneous. “[I]f a party believes its 12 deponent gave false testimony under oath, it may so explain to the fact-finder 13 during the normal course of the litigation.” Ashcraft, 2017 WL 5180421, at *6. 14 Raj can file an affidavit or provide testimony at trial explaining his mistaken 15 deposition testimony and the reasons for any corrections. He “will have a full 16 opportunity to explain his mistaken testimony at summary judgment or trial. The 17 finder of fact will have the opportunity to decide [Mr. Raj’s] credibility and 18 reliability on the facts in question, and may ultimately decide that he was honestly 19 mistaken about certain facts when he gave his deposition testimony.” Lewis v. 20 The CCPOA Benefit Trust Fund, 2010 WL 3398521, at *4 (N.D. Cal. Aug. 27, 21 2010). 22 2. 23 ViaSat contends that should the Court strike Raj’s deposition errata, the 24 errata of Acacia’s witness, Dr. Paul Prucnal, should similarly be stricken. The 25 relevant portion of Dr. Prucnal’s deposition transcript reads as follows: 26 Q: Well, the trade secret doesn’t specify what the demodulator is except that it’s a digital demodulator inside an adaptive equalizer. Correct? 27 Prucnal Deposition Errata 28 10 16cv463 BEN (JMA) 1 2 3 A: That’s correct. (Joint Mot., Ex. 8, Prucnal Dep., 112:11-15 [emphasis added].) Dr. Prucnal, in his deposition errata, seeks to amend his answer as follows: A: That’s correct. The trade secret doesn’t specify what the demodulator is except that it’s a digital demodulator that has certain features and is inside an optical receiver. 4 5 6 7 8 9 10 11 12 13 14 15 16 (Joint Mot., Ex. 10, Prucnal Dep. Errata.) As it turns out, there is an error in the transcription of the question: “adaptive equalizer” was used instead of “optical receiver.” See Prucnal Video Dep., https://d.warrenlex.com/2n51bQX (as visited Feb. 14, 2018); see also Joint Mot. at 18 n.11 (“Throughout this colloquy, the reporter mistranscribed counsel for ViaSat’s questions, substituting “adaptive equalizer (another term in the case) for “optical receiver.”). Acacia explains that Dr. Prucnal’s clarification was responsive to the actual transcript, that the transcription error rendered the question “gibberish on a technical level,” and that Dr. Prucnal clarified his answer in order to ensure it was not “misinterpreted as an admission to this gibberish.” (Joint Mot. at 10.) 17 18 19 20 21 22 23 24 25 26 27 The deposition transcript should be corrected to reflect the actual text of the question (“Well, the trade secret doesn’t specify what the demodulator is except that it’s a digital demodulator inside an optical receiver. Correct?”), which would render Dr. Prucnal’s clarification in his deposition errata moot. Dr. Prucnal’s original answer (“That’s correct.”) should stand without modification. C. Conclusion For the reasons set forth above, Acacia’s motion to strike is GRANTED. The Court STRIKES the following portions of Mr. Raj’s deposition errata sheet: 70:13, 71:3, 71:20-23, 72:3, 72:5, 83:3-4, 83:18, 84:14-16, 85:16-19, 85:23, and 86:2. The Court further STRIKES Dr. Prucnal’s deposition errata sheet at 112:15. The parties shall ensure the transcript of Dr. Prucnal’s deposition is 28 11 16cv463 BEN (JMA) 1 corrected as set forth above. 2 IT IS SO ORDERED. 3 Dated: February 15, 2018 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 12 16cv463 BEN (JMA)

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?